Podcasts about CGM

This episode is sponsored by HERS. HERS connects you with licensed healthcare professionals who create personalized treatment plans for your weight loss, hair growth, mental health, and skincare needs. Visit https://www.forhers.com/flipping to get your personalized treatment plan. Other Episodes You Might Like: Previous Episode - The Menopause Gut Health Fix You Did Not See Coming Next Episode - From Cancer to Coaching Women Through Change with Eliza Riley More Like This: 28-Day CGM Experiment: What I Learned This Time Answers to Your CGM Questions: For Nondiabetics Resources: Join the next CGM Challenge on January 1, 2026. Using this link gives you freebies and support! Don't know where to start? Book your Discovery Call with Debra. Leave this session with insight into exactly what to do right now to make small changes, smart decisions about your exercise time and energy. What we learned from wearing a CGM might just flip everything you thought you knew about food, sleep, and stress in midlife. Wearing a CGM is becoming a “thing.” It's almost trending.  I wish every doctor would recommend wearing a CGM to patients.  After completing a 28-day Continuous Blood Glucose Monitor (CGM) and Blood Sugar Challenge, I'm sharing exactly what they learned from wearing a CGM on day 29. 

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Blood sugar affects everything from your energy and sleep to your hormones and weight—yet most women are never taught how to manage it. In this episode, Kara Collier, RDN and co-founder of Nutrisense, shares what you need to know about CGMs, practical lifestyle hacks for glucose control, and the unique considerations women face after 35.Timestamps:[1:44] Intro[6:45] Interview with Kara[7:06] What did you see in your practice that made you realize blood sugar is a much bigger piece of the health puzzle?[10:51] Can you define what healthy blood sugar is, outside of markers on labs?[13:45] What does healthy blood sugar look like from a CGM perspective? [19:20] What's your opinion on why women are struggling more with blood sugar?[24:36] What do CGM's track and what data is most important? [36:10] Talk to me about the impact that stress has on our blood sugar and our ability to manage glucose.[41:06] What about exercise and sauna (the things that raise our heart rate)? What do we expect to see, what's normal, and what's not?[48:01] What are some of the most effective "hacks" in nutrition and exercise for blood sugar?[55:30] Do you think that carb timing influences blood sugar at all?[56:28] I got a CGM to see if there is anything obvious with my sleep.  Am I trying to avoid spikes all together? [1:03:04] How do we actually reverse insulin resistance? [1:09:56] Is fasting really good for blood sugar?[1:11:38] My 10 -year -old daughter has been wearing a CGM for about a month now. She has high anxiety and I noticed that when her anxiety is high, a juice box will calm her down at night. Once we put a CGM on her, we realize that her glucose is pretty low on average. How do we keep her glucose up without eating straight sugar all the time? What are some good glucose boosting snacks? Episode Links:Nutrisense CGMWell Minerals Vitamin CSponsors:Go to drinklmnt.com/wellfed and use code WELLFED to get a free 8-pack with any drink mix purchase!Go to curednutrition.com/wellfed and use code WELLFED for 20% off.Go to http://mdlogichealth.com/chocolate and use coupon code COLLAGEN15  for 15% off.Go to wellminerals.us/chill and use code WELLFED to get 10% off your order.

This episode is sponsored by BIOptimizers. BIOptimizers Magnesium Breakthrough contains an optimal ratio of all 7 types of Magnesium, formulated for maximum absorption. Get a 15% discount by using promo code Flipping50 at checkout. Other Episodes You Might Like: Previous Episode - Exercise Recovery After 40: Connective Tissue in Menopause Next Episode - 10 Things We Learned from Wearing a CGM, So You Don't Have To More Like This: Heal Your Gut, Save Your Brain It's Not Too Late to Overcome Gut Issues in Midlife Everything You Didn't Know About Your Menopause Gut Health (and Need to) The Biology of Trauma: Why All the Right Things Aren't Working in Menopause Resources: Join the Hot, Not Bothered! Challenge for your best start, restart or reset in or after menopause with 10 Days of coaching, short workouts, and clarity on how to exercise optimally. Don't know where to start? Book your Discovery Call with Debra. Leave this session with insight into exactly what to do right now to make small changes and smart decisions about your exercise time and energy. Aimee Apigan's Book - Biology of Trauma If you've been feeling off, it might be time for a Menopause Gut Health Fix — because when your gut's not in great shape, neither are you. Menopause gut health changes are so common yet the confusion and controversy is just as wide spread.  In this episode, I bring back a guest who also advises Gwyneth Paltrow. Got your attention? Good.  Here's why you want to listen: we talk about fiber, collagen, digestive enzymes, stomach acids and if you hang in there til the end one more thing related to menopause gut health fix you may not see coming. My Guest: Esther Blum is an Integrative Dietitian, bestselling author and keynote speaker who helps women find the light at the end of the vaginal tunnel through nutrition, hormones and self-advocacy. Known as Gwyneth Paltrow's menopause mentor, Esther has appeared on the Today Show, ABC-TV, and Good Day NY and is frequently quoted in goop, Oprah Daily, Well + Good, and Forbes. Questions We Answer in This Episode: [00:05:27] What signs show a woman's under-fueled in fiber, and how can she boost it without bloating or gut backlash? [00:30:30] Collagen's everywhere — where does it truly deliver for women over 45, and what needs to be in place for results? [00:18:11] How do you know if enzymes or Betaine HCl are really needed, and what mistakes do pros make here? [00:33:05] What is your stand on diet culture? For women “doing everything right,” what hidden weak link keeps results stuck? [00:40:09] What's next in gut-hormone science midlife women should watch before it hits mainstream?

Sixteen-year-old Eli shares how type 1 diabetes shaped his outlook on life, sports, and empathy—turning challenge into motivation and inspiring his dream of becoming an endocrinologist. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Sixteen-year-old Eli shares how type 1 diabetes shaped his outlook on life, sports, and empathy—turning challenge into motivation and inspiring his dream of becoming an endocrinologist. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

So many women in midlife are doing everything right (eating clean, exercising, managing stress) yet still feeling off. The missing link? Blood sugar.In this episode of The Well Drop, I sit down with Boris Berjan to explore how continuous glucose monitoring (CGM) is changing the way women understand their metabolism, hormones, and energy.We talk about why most CGMs give you numbers without context, how Theia translates those readings into clear daily scores, and the hidden ways stress, sleep, and even emotional triggers can spike glucose just like food.You'll learn how to spot early signs of blood sugar imbalance, how syncing your fasting and nutrition with your cycle can help balance hormones, and why data only matters when it's personal and easy to act on.Boris Berjan is the co-founder of Theia Health, a company reimagining continuous glucose monitoring (CGM) for women. He also shares his own healing journey and how it inspired him to build tech that puts real insight and power back into women's hands.What's Discussed:(00:00) Why midlife symptoms aren't just hormonal and how glucose plays a hidden role(04:49) The real reason most CGMs fail women in midlife(08:55) A personal story that inspired a smarter health tech(18:26) How this app turns confusing glucose data into simple, actionable insights(25:41) The role of AI in making nutrition and tracking more personal and easier(35:10) How stress, sleep, and emotions can spike glucose like carbs(38:20) The future of CGM technology and what's coming next(42:42) Making health data personal and empoweringThank You to Our Sponsors:Theia Health: https://theiahealth.ai/Find out more about Amber Berger:Website: www.thewelldrop.comInstagram: @thewelldropFind out more about Boris Berjan:Instagram: @borisberjan/Theia Health: https://theiahealth.ai/

In this episode, join Matt Edwards, CEO, GEMCO Medical and Heather Trumm, Partner Account Manager, VGM & Associates, as they explore the latest advancements in Continuous Glucose Monitoring (CGM) technology—from extended wear times to new pump integrations—making diabetes management easier and more effective for patients. We also unpack what these tech shifts mean for Home Medical Equipment (HME) providers, who are increasingly seen as the go-to experts in diabetes care. Learn how HMEs can strengthen patient relationships, support physicians, and grow their CGM business through best practices, strategic partnerships, and high-touch service models. Whether you're navigating market saturation or scaling operations, this conversation delivers actionable insights for forward-thinking providers.

In this Faces of Digital Health episode Dr. David Dodick, Chief Science and Medical Officer at the Atria Health Institute and Co-Chair of the Atria Research Institute talks about brain health, dementia prevention, the rapidly evolving science of Alzheimer's, and how digital tools and AI are transforming care. We also cover why women face higher Alzheimer's risk, the microvasculature's role in cognition, and the biggest leap in migraine treatment: CGRP-targeting therapies. A must-watch if you're curious about prevention, personalized risk, and which consumer tech is actually useful today. Dr. David Dodick trained at the Mayo Clinic and served on the faculty there for more than three decades. At the Mayo Clinic, he founded the Neurology Residency Program, the Headache Fellowship Program, the Sports Neurology and Concussion Program, the Migraine and Headache Program, and co-founded the Vascular Neurology/Stroke Program. What you'll learn: 1. How much dementia is realistically preventable—and how to lower your risk 2. Why amyloid ≠ destiny, and what “biological vs. clinical” Alzheimer's means 3. The role of sleep, hearing, blood pressure, metabolic health, and social connection 4. Smart wearables that matter (AFib, BP, CGM) and what's just hype 5. How AI “diagnostic orchestrators” could supercharge clinicians and empower patients 6. Migraine red flags (when to go to the ER) and the CGRP revolution in treatment

Marina Pavlovic Rivas, co-founder and CEO of Eli Health, reveals a revolution in personal health monitoring through advanced wearable devices. They discuss the journey from primitive step counters to sophisticated devices, such as continuous glucose monitors (CGMs) and the world's first instant hormone monitoring system by Eli Health. The conversation delves into the new cortisol testing kit from Eli Health, exploring its implications for understanding stress, sleep, metabolism, and overall health. Rivas explains the process of using the device, its integration with a smartphone, and how AI helps interpret the hormone data for actionable insights. Future plans for Eli Health's hormone monitoring technology, including progesterone and testosterone, are also discussed, offering a glimpse into the evolving landscape of self-monitoring and personalized health.

Dr. Hoffman continues his conversation with Marina Pavlovic Rivas, co-founder and CEO of Eli Health.

●YouTube影片● https://voh.psee.ly/8b2k4s ●FB粉專影片 ● https://voh.pse.is/8b2k99 本集主題：做一件很棒的事：52週控醣練習，吃出更好的自己 訪問：麥育瑋、劉亭妏 內容簡介： 《做一件很棒的事：52週控醣練習，吃出更好的自己》 出版本書跟發明好控麵™️的問世， 是因著日日好食想為讀者和其身邊的人， 提供更好的工具， 在控醣的路上走得輕鬆而長遠。 日日好食是什麼公司？ 全球第一位， 研發出好吃的控醣麵的公司。 好控麵™️符合華人口感與烹飪習慣，好吃到得國際獎食品界米其林iTQi二星獎章 控醣控到有數據，與一般麵條相比，對血糖有良性正向影響 出版「做一件很棒的事：52週控醣練習，吃出更好的自己」 一書，陪伴你建立正確的減醣知識及行動。 與醫師、營養師及健身教練深度合作。 每周一個小知識與小竅門， 每一碗簡單或豐盛的麵條。 慢慢的，潛移默化。 就吃出更好的自己。 作者簡介：日日好食創辦人　麥育瑋 好食頭，日日好食founder 國立中央大學中文系 國立師範大學大眾傳播研究所 國立台灣大學農業經濟研究所 公共電視台碩士論文獎學金得主 世界銀行事後評核訓練結訓 SLP第11屆學員 當過記者，跑立法院、經濟部。 做過國際開發援助機構計畫， 在非洲、亞太、中南美洲出差。 熱愛麵條。 源自於工作體會與自身需求， 開始研發最強麵條， 為了做出最強控醣麵條，開始研讀營養學， 為了說明麵條的美味，拿到國際食品獎 為了驗證對人體的影響，直接以CGM實測，以數據證明功效。 真誠認為， 好控麵可讓世界更好。 粉絲類： 日日好食 煮碗減醣麵 出版社粉絲頁： 一品文化出版社 #李基銘 #李基銘主持人#fb新鮮事#快樂玩童軍 #廣播之神#廣播之神李基銘 ●YouTube節目採訪頻道● https://voh.pse.is/83c4sg ●YouTube旅行採訪頻道● https://voh.pse.is/83c4p6 podcast平台，可以收聽 SoundOn　https://bit.ly/3oXSlmF Spotify　https://spoti.fi/2TXxH7V Apple　https://apple.co/2I7NYVc KKBOX　https://bit.ly/2JlI3wC Firstory　https://bit.ly/3lCHDPi 請支持粉絲頁 廣播之神：  / voh.god  李基銘主持人粉絲頁：  / voh.lee  李基銘-主持人-節目採訪頻道 ：  / voh.video  -- Hosting provided by SoundOn

I am a Type 2 Diabetic. I was diagnosed in December 2022.Since being diagnosed I have made a lot of life style changes with the goal of being off my diabetes medication.In November 2023 I achieved that goal. In April 2025 my doctor recommended I stopped using a Continuous Blood Glucose Monitor - CGM to monitor my blood glucose levels.I have a positive mindset that owns my diagnosis and response to it.This is my journey and my relationship with diabetes.I follow a Low Carbohydrate, high fat, high protein diet which has been successful in reducing my need for Metformin medication, CGM blood glucose monitoring and supported my weight loss.This is a video - and a podcast is available describing how I assemble my daily breakfast comprising whole foods, nutritious foods.Other meal preparations will come in the future Full details of the nutrient value in this meal are in the Blog Post on my website - www.markaashford.com

Send us a textPregnant? or coaching moms-to-be? Dr. Eric Westman and dietitian Lily Nichols, RDN (“Real Food for Pregnancy”) break down insulin resistance in pregnancy, the 175g carb myth, ketones vs. DKA, and real-food swaps that flatten CGM spikes—without piling on insulin.

Jessica Turton, Accredited Practising Dietitian, joins Dr. Michelle Woolhouse to discuss the use of continuous glucose monitors (CGM) to identify blood glucose dysregulation in non-diabetic patients in our latest podcast. Together, they discuss the role of the CGM in obtaining key, patient-specific information in terms of the blood glucose regulation of the individual, allowing for greater analysis of dietary, environmental and lifestyle influences on blood glucose regulation for the individual. Jessica and Michelle discuss the role stress, sleep and inflammation play in blood glucose regulation and share clinically practical advice on the role of magnesium deficiency in patients with blood glucose imbalances. Discussing the impact of certain exercises and alcohol, Jessica answers some of the many often-asked questions around how to best manage blood glucose levels for the non-diabetic patient. COVERED IN THIS EPISODE (01:03) Welcoming Dr Jessica Turton (01:53) What is continuous glucose monitoring (CGM)? (03:40) Using data from CGM to measure inflammation and blood glucose dysregulation (09:11) Optimal blood sugar targets throughout the day (13:45) The effects of high impact workouts on blood glucose (18:20) Hypoglycaemia vs reactive hypoglycaemia (24:30) Glucose metabolism, sleep apnea and magnesium wastage (28:06) Stress, exercise and glucose metabolism (32:34) Alcohol's effects on blood sugar (36:29) Patients' views on CGM (40:56) Thanking Jessica and final remarks Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/continuous-glucose-monitoring-with-dr-michelle-woolhouse-jessica-turton Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/ DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.

I am not a doctor. I do not provide medical advice. Always refer to your doctor for authoritative advice. I am a Type 2 Diabetic.  I was diagnosed in December 2022. Subsequently, I made numerous Lifestyle changes and by November 2023 my doctor ended my diabetes medication. I continued monitoring my blood glucose levels using a Continuous Blood Glucose Monitor—CGM. By April 2025, my doctor stopped the requirement to wear a CGM. With lifestyle changes and diligence, it was possible to reverse my diabetes naturally. I realized that if I had made the same changes over the previous 25–30 years, preventing my Type 2 Diabetes would have been entirely possible. Diabetes is one of the largest and fastest growing medical illnesses in all parts of the world. Preventing and reversing it when it has manifested is one of the biggest medical and personal challenges we face today.  This is my story and my journey.Carbohydrates and Diabetes BookeBookhttps://www.amazon.ca/dp/B0FY7X2GTDPaperback bookhttps://www.amazon.ca/dp/1997505304Audio Bookhttps://www.amazon.com/dp/B0FXDZ2LYB

Send us a textHow to humiliate a tyrant could be the subtitle to today's presentation. Haman is forced to honor his enemy, Mordecai, on the king's orders. If Haman had ceased from hating Mordecai, he could have changed his tomorrow, today. In this presentation, we will learn how to change our tomorrow through humility, how honoring others leads to blessings, how to deflect our enemy's attempts to curse us, and how God's timing in blessing us is perfect. My name is Stephanie Wright. Thank you for joining us in Episode 6, "Change Your Tomorrow, Today." My name is Stephanie Wright. Thank you for joining us today.Let's get started.  If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see the most recent video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Well-being science reveals that, despite signs of economic growth during the post-COVID recovery, a widespread "vibecession" phenomenon of U.S. consumer pessimism persists. This challenges the traditional economic assumption that increased discretionary income automatically translates into higher national happiness. To explore well-being science, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Carol Graham, a senior scientist at Gallup, an author, and a senior fellow in the Economic Studies program at Brookings. Carol discusses the lack of civic and economic education in the US and how that affects vulnerable populations. She also presents statistics on the decline of mental health and wellness among US teens and how a loss of hope contributes to consumer pessimism.This episode is proudly sponsored by:Calm—Offers the #1 app for sleep and meditation. Download Calm and find a place made just for you to rest. Visit Calm.com/HHTR Listeners get 40% off a Calm Premium Subscription. and LEAN—Offers clinically formulated weight management blended with ingredients that support metabolism, appetite control, and healthy fat utilization. Visit http://takelean.com/ and use promo code HHTR to get 20% off your order. and Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.

Well-being science reveals that, despite signs of economic growth during the post-COVID recovery, a widespread "vibecession" phenomenon of U.S. consumer pessimism persists. This challenges the traditional economic assumption that increased discretionary income automatically translates into higher national happiness. To explore well-being science, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Carol Graham, a senior scientist at Gallup, an author, and a senior fellow in the Economic Studies program at Brookings. Carol discusses the lack of civic and economic education in the US and how that affects vulnerable populations. She also presents statistics on the decline of mental health and wellness among US teens and how a loss of hope contributes to consumer pessimism.This episode is proudly sponsored by:Calm—Offers the #1 app for sleep and meditation. Download Calm and find a place made just for you to rest. Visit Calm.com/HHTR Listeners get 40% off a Calm Premium Subscription. and LEAN—Offers clinically formulated weight management blended with ingredients that support metabolism, appetite control, and healthy fat utilization. Visit http://takelean.com/ and use promo code HHTR to get 20% off your order. and Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.

On this accredited episode of NP Pulse: The Voice of the Nurse Practitioner, hear from experts Kathryn Evans-Kreider and Debbie Hinnen, who will be discussing the latest evidence and practical strategies for using continuous glucose monitoring (CGM) to improve outcomes, prevent complications and empower patients. NPs will learn how to apply current guidelines and expand CGM access across diverse patient populations. A participation code will be provided at the end of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center. Click on the "Next Steps" button of the activity and: Enter the participation code that was provided. Complete the posttest. Complete the activity evaluation. This will award your continuing education (CE) credit and certificate of completion. CE will be available through Oct. 31, 2026. Podcast Resource: ClinicalBrief_TacklingTherapeuticInertia.pdf This activity is supported by an independent medical educational grant from Abbott Diabetes.

A young listener turns the tables, interviewing Juicebox Podcast host Scott Benner about "fame", family, and 20 million downloads — a heartfelt, funny look at what he's learned along the way. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.

On this episode of Danatech Talks–a special series from The Huddle–Katrina Flaskerud, MS, RDN, LD, CDCES outlines some of the fundamentals of diabetes technology. Katrina provides a foundational overview of all of the devices out there today and how they differ from each other, how to have conversations with clients about what diabetes technology options may be best for them, and how diabetes care and education specialists and other health care professionals who are less familiar with diabetes technology can get started and learn more.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare Professionals  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textMost doctors still treat insulin resistance with medication but what if the real cure starts with food?

This week on the StartUp Health NOW podcast, we sit down with Sam Scott, PhD, CEO & Co-founder of Enhance-d, a Switzerland-based company transforming how people with diabetes approach exercise. Sam shares how his experience working with professional athletes living with Type 1 diabetes inspired a digital coaching platform that integrates CGM and wearable data to personalize workouts and improve glucose control. He also talks about the company's new clinical pilots with Dexcom, its growing global community of users, and the next generation of AI-powered coaching tools. Listen in to learn how Enhance-d is helping people with diabetes turn movement into medicine – and why collaboration across sports tech, med tech, and clinical care will shape the future of active diabetes management. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Every 8 seconds someone dies from complications of Type 2 Diabetes... Many people accept the medical model that Type two diabetes is a progressive disease that will only worsen but along the way can be managed with medications. Type two IS progressive if you continue to do the things you are doing that got you there in the first place. But what if there were things you could do to not only prevent Type II diabetes, but even reverse it to the point where it not longer exists in those that have it? What if you didn't even have to go to the doctor for this help?That is where "Diabetes Reversal Group" comes in. Dr. Jeffrey Hockings is the founder and CEO of Diabetes Reversal Group. He is also the author of two books on metabolic health and a sought-after speaker on the future of individualized medicine. Dr. Hockings joins us today.This Episode's Blog Page: https://drhaley.com/reversing-diabetesReversing Diabetes Website: https://www.diabetesreversalgroup.net/This episode on YouTube: https://www.youtube.com/watch?v=9JeQq_kOA5gDRG on YouTube: https://www.youtube.com/@diabetesreversalgroup367DRG on Instagram: https://www.instagram.com/diabetesreversalgroup/The Study that shows unvaccinated are healthier:https://www.thegatewaypundit.com/2025/10/bombshell-vax-vs-unvax-study-finally-sees-light/ https://pubmed.ncbi.nlm.nih.gov/33266457/TIMESTAMPS:00:00 Intro Snip01:40 Introduce Dr. Jeffrey Hockings and Diabetes Reversal Group02:23 What is the difference between type 1 and type 2 diabetes?03:16 What is Mainstream Medicine?05:50 What do chiropractors think the proper use of medicine is?07:00 Why did Dr. Jeffrey Hockings get into chiropractic?09:38 What "Power Words" were spoken into Dr. Haley's life by Dr. Bob Schiffman?11:30 What "Power Words" were spoken into Dr. Jeffrey Hockings life?12:54 Are there cases of Type 2 Diabetes that are not reversable?14:22 What other conditions is diabetes causing?16:31 What are the signs of Type 2 diabetes?18:40 How does Diabetes Reversal Group work using telemedicine?20:40 How are medications like Ozempic impacting diabetes treatment?22:20 What is the patient experience like at Diabetes Reversal Group?24:00 How do they monitor their blood sugar levels?25:09 What is better, the finger stick or the CGM?29:23 Dr. Haley invites anyone wearing a CGM to participate in a case study with aloe vera30:25 What is a favorite success story?32:08 What are the blood sugar and A1C measurements to be concerned about?34:24 What are the acceptable blood sugar levels?39:40 What is Dr. Jeffrey Hockings proof that people are brainwashed?42:10 Dr. Hockings discusses a study where vaccinated and unvaccinated children were compared (link in resources).43:29 Dr. Haley explains his "pro-vaccine" approach47:03 Dr. Haley explains his brain washing research48:50 How is exercise incorporated into the program?49:40 How can exercise be bad for a diabetic?54:00 Where is the best first stop to find out more? reverseyourdiabetes.com

Misinformation is aggressively injected into the information ecosystem, and it is readily consumed and adopted by those who are too busy to fully pay attention, leveraging cognitive bias in a distracted society. This media manipulation is often fueled by financial incentives, rewarding so-called experts who deliver false narratives in entertaining and engaging ways. This weighs the heaviest on society when politicians can't agree on policy because they can't agree on facts. To search for the tools of truth, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Adam Berinsky, author and the Mitsui Professor of Political Science at MIT. Adam dissects the psychology of misinformation, by examining those who create it with malicious intent, the villains who disseminate it for profit, and the audience most likely to adopt it without question. This episode is proudly sponsored by:Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.

Sane Mazibuko's introduction to type 1 diabetes was waking up in hospital after collapsing as a 6-year-old. But as she tells us in this heartfelt episode, being told what to do to manage a health condition is not the same as being told why or how.Growing up in Durban, South Africa, Sane had moved across the country as an adult before she spoke to her first endocrinologist, and after years of confusing and isolating experiences, she eventually found the support team that allowed her to be honest about her condition.29 years into life with type 1 diabetes, Sane now uses the information and experience she's gathered to help others in South Africa and beyond to better understand the life it's possible to live with the condition, from eating the same foods as everyone else to workplace support, to coming back from burnout. As she says on her social media, Sane's decision to ‘choose softness daily', is helping her move through the challenges that type 1 diabetes endlessly presents. Sane also talks poignantly about educating her young daughter about her mum's diabetes, including being able to understand Sane's CGM readings

Misinformation is aggressively injected into the information ecosystem, and it is readily consumed and adopted by those who are too busy to fully pay attention, leveraging cognitive bias in a distracted society. This media manipulation is often fueled by financial incentives, rewarding so-called experts who deliver false narratives in entertaining and engaging ways. This weighs the heaviest on society when politicians can't agree on policy because they can't agree on facts. To search for the tools of truth, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Adam Berinsky, author and the Mitsui Professor of Political Science at MIT. Adam dissects the psychology of misinformation, by examining those who create it with malicious intent, the villains who disseminate it for profit, and the audience most likely to adopt it without question. This episode is proudly sponsored by:Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.

In this episode of the PCOS Repair Podcast, you'll explore how luteinizing hormone (LH) plays a pivotal role in ovulation, and how its interaction with insulin can create hormonal chaos in PCOS. LH is the hormone responsible for triggering ovulation, but when it becomes imbalanced, cycles can become irregular or even anovulatory. This discussion sheds light on why LH may be elevated and how this elevation disrupts ovulation, especially when paired with high testosterone levels.How Cycle Chaos Unfolds: Elevated LH and OvulationInsulin resistance, common in PCOS, contributes to elevated testosterone and disrupts LH levels. Even without insulin resistance, women with PCOS may experience high insulin levels due to dietary habits. This elevation prompts the ovaries to produce more testosterone, which in turn increases LH. The result? Disrupted ovulation, missed LH surges, and cycles that are difficult to interpret.When LH levels are chronically elevated, the body misses the distinct surge that's necessary for ovulation to occur. You'll discover how this prevents egg release, contributes to cystic ovaries, and leads to inconsistent or missed periods. Practical Tools to Lower Insulin and Restore OvulationYou'll learn practical strategies for lowering insulin and restoring hormone balance. This includes optimizing nutrition and strategic eating patterns to support better glucose regulation and lower daily insulin loads.For deeper insight into how your body handles food and stress, a CGM can be a powerful tool. In this episode, you'll learn how to use a CGM to observe patterns, make small dietary changes, and experiment with meal timing and movement to lower insulin responses and improve hormone balance.Exercise is another key lifestyle tool for improving insulin sensitivity. You'll hear how Zone 2 exercise and strength training help your body use insulin more efficiently. These simple habits can dramatically reduce post-meal glucose spikes and improve overall hormonal function.Stress is a major hormone disruptor. You'll discover how elevated cortisol increases insulin, promotes fat storage, and throws off hormonal rhythms, including LH and ovulation. This episode covers how daily stress management practices are essential to support hormonal healing.Supporting Ovulation with SupplementsOnce foundational root causes are addressed, well selected supplements can further support insulin sensitivity and ovulation. This episode explains when and how to incorporate these supplements and provides resources for trusted product recommendations.If you've struggled to interpret LH tests, manage irregular ovulation, or understand the hidden factors behind PCOS symptoms, this episode breaks it down in a clear, practical way. You'll leave with an understanding of how insulin impacts LH and what daily strategies, like movement, food timing, and supplements, can help regulate this delicate hormonal balance.You can take the quiz to discover your root cause hereGet the PCOS Supplement Guide for trusted product recommendations and discounts. Let's continue the conversation on Instagram! What did you find helpful in this episode and what follow-up questions do you have?The full list of Resources & References Mentioned can be found on the Episode webpage at:https://nourishedtohealthy.com/ep-169

Scott talks with Marley, mom to one-year-old Bane, diagnosed after DKA and a life flight. From ICU to CGM and Mobi, she shares hard-won reality, faith, and growing TikTok advocacy. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Hey, I'm Ben Tzeel. In this quick episode, I explain why blood sugars often creep up in fall and it's not just pumpkin treats! We talk about the under the radar role of temperature and season changes, how less daylight and fewer steps can sneakily raise your numbers, and what to check in your data. I share a personal story about steps saving my day and give practical tips: look at your CGM or logs, message your care team about medication adjustments, and plan for holiday foods so you can enjoy them without getting derailed. Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider   LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel  

Send us a textWe are celebrating five years of podcasting in 2025 by revisiting our archives and rebroadcasting select episodes since June 20, 2020. This is Stephanie Wright. Thank you for joining us for Episode 18, “One Thing” from the Queen Esther series. Let's get started.One thing, one thing. Today, we are asking a very important question. What is that one thing that is holding you back from your blessings? Haman, who had blessings beyond what he deserved could not see the blessings because he was so consumed with hatred for Mordecai. Today, we look at the one thing that led to Haman's demise. Let's go to our presentation, Queen Esther, "One Thing." If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see the most recent video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

This week, we're diving into 2 wins, 2 breakdowns, and one massive comeback in our Type 1 Diabetes lives. If you're here for perfect graphs and flawless time-in-range, you're on the wrong podcast. But if you want honesty, swearing, laughter, and actual real-life T1D chaos — welcome home. ❤️In this episode, we talk mental health, time-in-range battles, Libre vs Dexcom drama, night-time spikes, morning glory (yep, still a thing), and why sometimes the biggest win is just not rage bolusing yourself into oblivion. We also bring back Win of the Week and admit which one of us is addicted to crisps. Again.In this episode:

Scott talks with Marley, mom to one-year-old Bane, diagnosed after DKA and a life flight. From ICU to CGM and Mobi, she shares hard-won reality, faith, and growing TikTok advocacy. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team's quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.” This episode covers:Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinicKey interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreachLessons for advancing equitable implementation and sustaining quality improvement over time Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here.

Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Scott and Jenny name and define the blood sugar “shapes” seen on CGM graphs—bell curves, spikes, plateaus, roller coasters—to create a shared language for understanding glucose patterns. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Send us a textIn this episode, Anne Lemus, a Fit Body Fusion coach, master's athlete, and menopause advocate, dives deep into the science and strategy behind hormone replacement therapy (HRT) and women's health. She explains the crucial difference between being “medically in range” and being personally optimal, helping listeners understand how to interpret and track their thyroid, cortisol, and hormone panels for genuine well-being. The episode highlights how to properly prepare for lab testing—covering hydration, fasting, and timing—and how lifestyle factors such as sleep, stress management, and nutrition directly influence hormone balance. With practical insights on functional health, inflammation, and continuous glucose monitoring (CGM), Anne empowers women to take charge of their health and discover what true hormonal balance feels like.Anne Lemus is a dedicated IFBB Bikini Pro and experienced Fitness & Nutrition Coach, empowering individuals to transform their health and achieve their physique goals through balanced strategies and sustainable habits. With a strong foundation in competitive bodybuilding, Anne uses her expertise to guide clients through tailored fitness programs and personalized nutrition plans that promote strength, confidence, and long-term success. Her journey as a professional athlete fuels her passion for helping others unlock their full potential, whether they're stepping on stage or striving for a healthier lifestyle. Anne's coaching philosophy focuses on creating balance, fostering self-discipline, and embracing the mindset needed for lasting results.

An ICU nurse mom recounts her child's type 1 diabetes DKA diagnosis, winning school CGM monitoring, juggling celiac, and data-driven management with pump/CGM—practical advocacy and tactics parents can replicate. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it.

If you've ever been told your blood sugar is “normal” but you still feel tired, anxious, or can't sleep, this episode is for you.Most people think blood sugar only matters if you have diabetes. But the truth is, your blood sugar impacts every single system in your body... from your energy and sleep to your hormones, cravings, and mood.In this episode, Dani breaks down what blood sugar actually does in the body, the subtle signs it's off (even when your labs look fine), and how modern life, from artificial light to chronic stress, quietly disrupts metabolic health. You'll learn why these issues go far beyond food and how your circadian rhythms, nervous system, digestion, minerals, and mitochondria all play a role in keeping you balanced.You'll walk away understanding why steady blood sugar is foundational for optimal energy, hormones, mood, and long-term health.

Send us a textA 35% drop in liver fat in under a week sounds impossible—until you see how a simple macro shift can redirect your metabolism. We dive into a Danish crossover study where calories stayed equal, protein held steady, and the only real change was carbohydrates versus fat. The result: rapid reductions in hepatic fat, lower triglycerides, improved insulin sensitivity, and clear signs of metabolic flexibility, all in four to five days. We unpack what that means for everyday eating, how to use CGM feedback to reduce glucose spikes, and why outcomes like organ fat and fat oxidation should trump a single lipid reading taken out of context.From there, we widen the lens. Fatty liver—now recognized as a hallmark of metabolic dysfunction—is staggeringly common, yet highly responsive to nutrition quality and distribution. We break down why modest carb moderation paired with quality fats and robust protein can stabilize energy, support endogenous GLP-1 signaling, and protect lean mass. We also confront a common confusion: “high fat” isn't a license for ultra-processed oils or low-fiber meals. When fats come from olive oil, avocado, nuts, eggs, and fish—and plants supply fiber and polyphenols—the microbiome, mitochondria, and glycemic control can all improve together.We close with practical implications for anyone using GLP-1 medications. Pharmacology can provide short-term traction, but it doesn't guarantee nourishment. A protein-forward, lower-glycemic template plus resistance training helps preserve muscle, sustain satiety, and potentially reduce medication reliance over time. If you're ready to swap shaky biomarkers for meaningful outcomes—and to see changes fast—this conversation offers a clear, evidence-backed roadmap. If it resonates, follow the show, share with a friend, and leave a quick review to help more listeners find The Health Edge.www.thehealthedgepodcast.com

In this episode of The Lisa Fischer Said Podcast, Lisa sits down with Kara Collier, registered dietitian and co-founder of Nutrisense, to unpack the truth about metabolic health, insulin resistance, and how continuous glucose monitors (CGMs) are transforming the way we understand our bodies. Kara shares why she left traditional healthcare, the shocking flaws in hospital nutrition, and how real-time data from CGMs empowers behavior change. Whether you're keto, carnivore, plant-based, or just curious, this episode reveals why everyone should wear a CGM at least once. Learn how glucose, insulin, fasting, aging, and hormones all play into the metabolic puzzle—and how Nutrisense is helping thousands take control of their health.     WEBSITE: https://www.karacollier.com/courses/GlucoseAcademy     Nutrisense Page with 33% Discount: https://www.nutrisense.io/marketing/kara-collier     INSTAGRAM: https://www.instagram.com/karacollierrd/     INSTAGRAM:  https://www.instagram.com/nutrisenseio/     FACEBOOK: https://www.facebook.com/nutrisenseio     EPISODE SPONSOR:  https://www.davidsburgers.com/     EPISODE SPONSOR:  https://marlsgate.com     LISA'S LINKS:     Lisa Fischer Said Academy:  https://lisafischersaid.com/academy/     Website:  lisafischersaid.com     For more information on group intermittent fasting  coaching with Lisa, email fasting@lisafischersaid.com     For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com     Podcast produced by clantoncreative.com    

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

‣ Book Your COMPLEMENTARY CONSULATION and CALORIE CALCULATION call:- how much & what to eat, exercise & lifestyle recommendations, and specific resources to support you on your journey

The glucose projector is a simple but powerful idea that can only come from someone who lives with type 1 – and sleeps with it! John DeLeo created a digital readout of CGM data that displays the number, and the time, right on the ceiling. John was diagnosed with type 1 in his 40s. We'll talk about his diagnosis, what lead him to this invention, the long road of bringing it to market, and more. Learn more about Glucose Projector here  This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Although aging is an inevitable part of life, there are many factors in our control that can help us live long, vibrant lives. Through healthy lifestyle habits, you can actually slow down the biological aging process. Today, you're going to learn the key strategies that can help you reach this goal. On this episode of The Model Health Show, you're going to learn about seven science-backed ways you can slow down your aging process. We're going to cover supplementation, exercise, mindset, and so much more! You're going to hear the latest studies on antiaging, plus tips from some of the top longevity experts. Plus, for each of these tips, I'm going to share some tangible takeaways you can implement immediately. If you want to slow down your aging process and get healthier as you age, this episode is for you. Enjoy!   In this episode you'll discover:  How vitamin D supplementation can reduce telomere shortening. (0:42) What telomeres are. (1:30) The percentage of Americans that are vitamin D deficient. (2:07) Which form of vitamin D to take for antiaging benefits. (3:18) How your sleep quality impacts biological aging. (4:30) The link between sleep and telomeres. (5:32) Why having a consistent sleep schedule is critical for your health. (6:05) The role of sunlight exposure in regulating your circadian rhythm. (13:39) How your gut microbiome can dictate your aging process. (22:45) The importance of eating a diverse range of foods. (26:31) How many servings of fermented foods per week to eat for gut health. (31:09) Why meditation can slow down your aging process. (31:30) The power of having adequate muscle on your body. (38:37) How much tea to drink daily for antiaging effects. (46:08) The incredible role your mind plays in impacting your rate of aging. (49:40) Why being playful can help you live longer. (58:02)  Items mentioned in this episode include:  Levels.link/model  - Join today and get 2 free months with a one-year membership! Piquelife.com/model  - Get exclusive savings on bundles & subscriptions! These 4 Things Are Destroying Your Sleep Quality  - Get better sleep tonight! Eat These Foods to Improve Your Sleep Quality  - Learn about the link between nutrition & sleep! Visualization Secrets Athletes Use  - Hear the interview with Maya Raichoora Seasonal Food Guide  - Find which foods are in season in your area!  Be sure you are subscribed to this podcast to automatically receive your episodes:   Apple Podcasts Spotify Soundcloud Pandora YouTube   This episode of The Model Health Show is brought to you by Levels and Pique. Learn how food affects your health with a continuous glucose monitor (CGM) from Levels. Join today at levels.link/model and get 2 free months with a one-year membership! Go to Piquelife.com/model for exclusive savings on bundles & subscriptions on cutting-edge solutions for your head-to-toe health and beauty transformation. 

B is  the mom of a T1D son who was diagnosed at a 16 months. He is currently 2 and they are about 9 months in to managing diabetes.  Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

I am delighted to have Jessie Inchauspé, the Glucose Goddess, joining me on the podcast today! Metabolic health is my passion! It is a huge area of focus in my work, and Jessie is truly a gift in the space! She is a rising star author and biochemist with a clear and accessible way of explaining the science behind glucose metabolism.  Jessie joins me today to discuss the impact of glucose metabolism and spikes. We dive into her background and how an accident created her pain-to-purpose story. We discuss the role of continuous glucose monitors and how glucose spikes impact our mitochondria, inflammation, and oxidative stress. We get into glycation and aging, how weight gain is a protective aspect of glucose spikes- or hyperglycemia, and the role of vinegar, movement, and fiber. We also talk about Jessie's new book, her opinions on fasting, and so much more.  I loved interviewing Jessie! Her enthusiasm is contagious, and it is easy to understand why she is such a beloved author in the health and wellness space! IN THIS EPISODE YOU WILL LEARN: Jessie shares how an accident led her to where she is today. Wearing a continuous glucose monitor (CGM) changed everything for Jessie How Jessie developed her simple principles to stabilize glucose levels What is the purpose of glucose in the body? Glucose spikes and our mitochondria Vinegar hack for reducing side effects and symptoms of glucose spikes Being metabolically unhealthy impacts the aging process Benefits of having savory breakfasts and eating vegetables first with every meal Jessie's book, The Glucose Goddess Method How gaining weight protects our bodies from the impact of glucose spikes Walking or moving after meals to balance blood sugar levels Why blood sugar so important Connect with Cynthia Thurlow Follow on X Instagram LinkedIn Check out Cynthia's website Connect with Jessie Inchauspé On her website   Instagram Link for Jessie's new book: Buy a copy of Jessie's book, The Glucose Goddess Method.

My guest is Michael Snyder, PhD, professor of genetics at Stanford and an expert in understanding why people respond differently to various foods, supplements, behavioral and prescription interventions. We discuss how to optimize your health and lifespan according to what type of glucose responder you are, which genes you express, your lifestyle and other factors. Dr. Snyder also explains the key ages when you need to be particularly mindful about following certain health practices. We also discuss how people respond in opposite ways to different fiber types. This episode ought to be of interest and use to anyone seeking to understand their unique biological needs and how to go about meeting those needs. Sponsors AGZ by AG1: https://drinkag1.com/huberman Wealthfront*: https://wealthfront.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman *This experience may not be representative of the experience of other clients of Wealthfront, and there is no guarantee that all clients will have similar experiences. Cash Account is offered by Wealthfront Brokerage LLC, Member FINRA/SIPC. The Annual Percentage Yield (“APY”) on cash deposits as of December 27,‬ 2024, is representative, subject to change, and requires no minimum. Funds in the Cash Account are swept to partner banks where they earn the variable‭ APY. Promo terms and FDIC coverage conditions apply. Same-day withdrawal or instant payment transfers may be limited by destination institutions, daily transaction caps, and by participating entities such as Wells Fargo, the RTP® Network, and FedNow® Service. New Cash Account deposits are subject to a 2-4 day holding period before becoming available for transfer. Timestamps 00:00 Michael Snyder 03:33 Healthy Glucose Range, Continuous Glucose Monitors CGM, Hemoglobin A1c 09:02 Individual Variability & Food Choice, Glucose Spikes & Sleepiness 12:18 Sponsors: AGZ by AG1 & Wealthfront 15:16 Glucose Spikes, Tools: Post-Meal Brisk Walk; Soleus “Push-Ups”; Exercise Snacks 21:06 Glucose Dysregulation, Diabetes & Sub-Phenotypes, Tool: Larger Morning Meal 28:34 Exercise Timing, Muscle Insulin Resistance 30:49 Diabetes Subtyping, Weight, Glucose Control; Incretins 35:41 GLP-1 Agonists, Diabetes, Tool: Muscle Maintenance & Resistance Training 38:40 Metformin, Berberine, Headaches 41:01 GLP-1 Agonists, Cognition, Longevity, Tool: Habits Support Medication; Cycling 47:41 Subcutaneous vs Visceral Fat, Organ Stress 49:10 Sponsors: David & Eight Sleep 51:58 Meal Timing & Sleep, Tools: Post-Dinner Walk, Routines, Bedtime Consistency 57:16 Microbiome, Immune System & Gut; Diet & Individual Variability 1:02:52 Fiber Types, Cholesterol & Glucose, Polyphenols 1:09:50 Food As Medicine; Fiber, Microbiome & Individual Variability; Probiotics 1:18:48 Sponsor: Function 1:20:35 Profiling Healthy Individuals, Genomes, Wearables 1:26:31 Whole-Body MRIs, Nodules, Healthy Baseline, Early Diagnosis 1:34:07 Sensors, CGM, Sleep, Heart Rate Variability HRV, Tools: Mindset Effects, Increase REM 1:39:30 HRV, Sleep, Exercise, Tool: Long Exhales; Next-Day Excitement & Sleep 1:42:48 Organ Aging, “Ageotypes”; Biological Age vs Chronological Age 1:49:41 Longevity, Health Span, Genetics, Blue Zones 1:52:19 Epigenetics, Viral Infection & Disease 1:58:54 ALS, Heritability; Neuroprotection, Nicotine 2:03:47 Air Quality, Allergies, DEET & Pesticides, Inflammation, Mold; Microplastics 2:15:02 Single-Drop Blood Test & Biomarkers, Wearables, Observational Trials 2:20:33 Acupuncture, Blood Pressure 2:26:40 Immersive Events & Mental Health Benefits 2:34:59 Data, Nutrition & Lifestyle; Siloed Health Care vs Personalized Medicine 2:43:06 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Social Media, Neural Network Newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Dominic D'Agostino (@DominicDAgosti2) is a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine and a Visiting Senior Research Scientist at the Institute for Human and Machine Cognition.This episode is brought to you by: Helix Sleep premium mattresses: https://HelixSleep.com/Tim (27% off all mattress orders)Momentous high-quality creatine: https://livemomentous.com/tim (code TIM for up to 35% off)AG1 all-in-one nutritional supplement: https://DrinkAG1.com/Tim (1-year supply of Vitamin D plus 5 free AG1 travel packs)Timestamps:[00:00:00] Start.[00:14:43] Why I'm interested in ketogenic strategies for neurodegenerative prevention.[00:16:18] Mary and Steve Newport's ketone-linked temporary cognitive improvements.[00:18:18] A mechanisms overview for Alzheimer's/dementia.[00:21:25] The immune system as longevity's "fifth horseman" — and why metabolic control is key.[00:22:04] How to measure ketones and GKI.[00:23:00] Fasting vs. ketogenic diet.[00:24:18] There's nothing fishy about sardine fasting.[00:28:32] My hiatal hernia discovery and increased cancer risk concerns.[00:30:04] HSCRP as a superior biomarker to LDL for cardiovascular risk.[00:31:57] Glucose tolerance testing revelations and CGM importance.[00:31:57] Upgrading the metabolic machinery through keto without getting bored.[00:42:07] What do do if you, like Dom and me, are among the 30% who suffer from cholesterol hyperabsorption.[00:43:42] Dom's day-to-day diet regimen.[00:45:56] How Dom optimizes his aging dogs with ketones, SARMs, and supplements.[00:51:30] Supplementing for sleep disruption while fasting.[00:55:41] Why Dom doesn't have misgivings about melatonin.[00:59:15] Shingles prevention through fasting protocols.[01:00:15] Immune system modulation: Innate vs. adaptive, vegan vs. ketogenic.[01:03:54] Dom at 50-something: Current meal timing and composition.[01:05:57] Blue zone observations: Greek and Sardinian longevity habits.[01:08:16] Ketogenic diet initiation tips: MCT, electrolytes, and fasted cardio.[01:15:18] Ketone metabolic therapy for cancer.[01:18:15] The metabolic psychiatry revolution.[01:22:10] The soothing effects of hyperbaric oxygen and ketosis on seizure sufferers.[01:28:27] Metformin vs. berberine.[01:31:43] The low-dose neuroprotective potential of GLP-1 drugs.[01:34:58] NAD research: MIB-626 and stabilized forms for mitochondrial health.[01:39:48] Idebenone, CoQ10, and the Deanna protocol for ALS.[01:42:05] Dom's supplement short list: CoQ10, creatine, ketones, vitamin D, melatonin.[01:44:43] KetoNutrition.org, Metabolic Health Summit, Audacious Nutrition, veteran-focused research protocols, and other parting thoughts.*Show notes for this episode: https://tim.blog/2025/09/03/dr-dominic-dagostino-all-things-ketones/For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.